Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-24

Clinical Trial Update: Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD

View source ↗

Summary

A clinical trial evaluating endothelial function-guided therapy versus usual care in patients with non-obstructive coronary artery disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Itamar-Medical, Israel | Conditions: Coronary Atherosclerosis | Status: WITHDRAWN